Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Biologicals and biosimilars, what

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: DECLERCK, Paul J (KU Leuven, Pharmaceutical and Pharmacological Sciences, Leuven, Belgium)
  • Abstract:

    Biosimilars are copies of approved biopharmaceuticals for which the patent has expired.The concept of biosimilars has been introduced in the world of biopharmaceuticals since 2005.
    Biopharmaceuticals are intrinsically characterized by a significant heterogeneity which on its turn is highly dependent on the expression system, culture conditions,..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses